Evidence map›Paper›PMID 10393948›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome.

N J Smilinich, C D Day, G V Fitzpatrick, G M Caldwell, A C Lossie, P R Cooper, A C Smallwood, J A Joyce, P N Schofield, W Reik and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 406 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Natural antisense transcript ofGenes & development · 2021
    Article
  17. Article
  18. Pseudogenes: A Novel Source of Trans-Acting Antisense RNAs.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Review
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

N J SmilinichDepartment of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
C D Day
G V Fitzpatrick
G M Caldwell
A C Lossie
P R Cooper
A C Smallwood
J A Joyce
P N Schofield
W Reik
R D Nicholls
R Weksberg
D J Driscoll
E R Maher
T B Shows
M J Higgins
Center for Human Genetics · USHospital for Sick Children · CABabraham Institute · GBFlorida College · USRoswell Park Comprehensive Cancer Center · USUniversity Hospitals of Cleveland · US

Funding

TUMOR SUPPRESSORS AND IMPRINTING AT CHROMOSOME 11P155R01CA063333 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI HIGGINS, MICHAEL J · 1994 to 2000
$353k
NCI NIH HHS CA63333Wellcome Trust
6 · The paper itself

Abstract

Loss of imprinting at IGF2, generally through an H19-independent mechanism, is associated with a large percentage of patients with the overgrowth and cancer predisposition condition Beckwith-Wiedemann syndrome (BWS). Imprinting control elements are proposed to exist within the KvLQT1 locus, because multiple BWS-associated chromosome rearrangements disrupt this gene. We have identified an evolutionarily conserved, maternally methylated CpG island (KvDMR1) in an intron of the KvLQT1 gene. Among 12 cases of BWS with normal H19 methylation, 5 showed demethylation of KvDMR1 in fibroblast or lymphocyte DNA; whereas, in 4 cases of BWS with H19 hypermethylation, methylation at KvDMRl was normal. Thus, inactivation of H19 and hypomethylation at KvDMR1 (or an associated phenomenon) represent distinct epigenetic anomalies associated with biallelic expression of IGF2. Reverse transcription-PCR analysis of the human and syntenic mouse loci identified the presence of a KvDMR1-associated RNA transcribed exclusively from the paternal allele and in the opposite orientation with respect to the maternally expressed KvLQT1 gene. We propose that KvDMR1 and/or its associated antisense RNA (KvLQT1-AS) represents an additional imprinting control element or center in the human 11p15.5 and mouse distal 7 imprinted domains.

Indexed as

Chromosomes, Human, Pair 15Genomic ImprintingMembrane ProteinsPotassium Channels, Voltage-GatedTranscription, GeneticAnimalsBase SequenceBeckwith-Wiedemann SyndromeCell LineChromosome MappingDinucleoside PhosphatesDNADNA, AntisenseDNA MethylationFemaleHumansCpG dinucleotideDinucleoside PhosphatesDNADNA, AntisenseKCNQ1OT1 long non-coding RNA, humanKCNQ1 Potassium ChannelKCNQ1 protein, humanKcnq1 protein, mouseKCNQ Potassium ChannelsMembrane ProteinsPotassium ChannelsPotassium Channels, Voltage-Gated

Identifiers

PMID10393948
PMCPMC22188
OpenAlexW2043203820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.